ADMA BIOLOGICS, INC.: capex
| Value | {"amount": -245675, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-06-30 |
| Status | current |
| Entity | ADMA BIOLOGICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:01.190291+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ebb75a65-a4f4-469e-9d86-81c0ab49588d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193805-20-000960Retrieved: 2026-08-19T13:07:01.190291+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001368514/capex/2019-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ebb75a65-a4f4-469e-9d86-81c0ab49588d
History
- supersedes {"amount": 245675, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001193805-19-000715)